Autoplaque vs inHEART Models

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by APQ Health (formerly Cedars-Sinai Medical Center: AIM)
VS
by inHEART

AI Verdict

Autoplaque specializes in quantitative analysis of coronary plaques and stenoses from CT angiography for heart attack risk prediction and treatment guidance. In contrast, inHEART Models creates detailed 3D digital twin models of the heart from CT/MR images to optimize planning and execution of cardiac ablation procedures. While both leverage AI for cardiac imaging, their distinct clinical applications make them suitable for different stages of cardiac care and different cardiac conditions.

Choose Autoplaque if…

Choose Autoplaque if your primary objective is to perform quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for aiding in heart attack risk prediction and guiding non-invasive treatment strategies by providing detailed, AI-powered insights into atherosclerotic plaque characteristics.

View Autoplaque →

Choose inHEART Models if…

Choose inHEART Models if you need to create highly detailed 3D digital twin models of the heart from CT/MR images for optimizing the planning and execution of image-guided cardiac ablation procedures. This cloud-based solution is particularly beneficial for electrophysiologists aiming to enhance procedural efficiency and improve patient outcomes through advanced pre-procedural visualization and integration with electroanatomic mapping systems.

View inHEART Models →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Autoplaque inHEART Models
Pricing Unknown Contact for pricing
Deployment Workstation-based post-processing application, runs on Windows or Mac OS. Cloud-based
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

inHEART Models

inHEART Models offers superior usability due to its cloud-based platform, enabling interactive exploration and accessibility from various devices. Crucially, it provides seamless integration with major electroanatomic mapping (EAM) systems, streamlining complex interventional cardiology workflows.

Clinical Value

inHEART Models

While both tools are FDA-cleared and clinically validated, inHEART Models demonstrates a more direct and quantifiable impact on patient outcomes for complex procedures. It has shown the potential to reduce VT procedure times by 60% and recurrence rates by 38%, significantly improving efficiency and efficacy in high-stakes cardiac ablations.

Pricing & Value

inHEART Models

Direct pricing for both tools is not publicly disclosed, making a direct cost comparison impossible. However, inHEART Models has a specific CMS reimbursement code (C9793) with an allowed amount of $996.18 for 3D predictive model generation, which provides a clear pathway for reimbursement and indicates recognized value by CMS.

Enterprise Readiness

inHEART Models

inHEART Models is cloud-based, offering inherent scalability and easier management for large healthcare systems, and explicitly mentions SOC2 compliance, suggesting robust data security and HIPAA readiness. Its proven integration with major EAM systems and reported use in over 300 partner hospitals further demonstrates strong enterprise readiness.

Innovation

inHEART Models

inHEART Models exhibits a higher degree of innovation with its 'AI-enabled digital twin of the heart' concept, providing highly detailed, interactive 3D cardiac models for optimizing complex ablation procedures. Its 'first-of-its-kind' fully automated CT image segmentation for 3D cardiac models represents a significant advancement in interventional cardiology.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer sufficient specific information regarding customer support channels, service level agreements, or comprehensive public documentation for either Autoplaque or inHEART Models to differentiate between them.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Autoplaque inHEART Models
Name Autoplaque inHEART Models
Company Cedars-Sinai Medical Center: AIM inHEART
Description Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. inHEART Models is an AI-driven software that creates detailed 3D digital twin models of the heart from CT/MR images, optimizing planning and execution of image-guided cardiac ablation procedures.
Key Features AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area AI-driven digital twin of the heart; Automated segmentation of CT and MR images; Highly detailed, interactive 3D cardiac models; Pre-procedural planning and optimization of treatment strategies; Seamless integration with major electroanatomic mapping (EAM) systems (Cartou00ae, Rhythmiau2122, Ensiteu2122, Afferau2122); Potential to reduce VT procedure times by 60%; Potential to reduce VT recurrence rates by 38%; Cloud-based platform for interactive exploration

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and inHEART Models.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Autoplaque is designed for the quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. In contrast, inHEART Models creates detailed 3D digital twin models of the heart from CT/MR images to optimize the planning and execution of image-guided cardiac ablation procedures.
Autoplaque performs analysis using CT angiography images. inHEART Models is capable of creating 3D heart models from both CT and MR images.
Autoplaque provides AI-powered quantitative analysis of atherosclerotic plaque, including detection, characterization, and measurement of luminal stenoses. inHEART Models generates highly detailed, interactive 3D digital twin models of the heart for pre-procedural planning.
inHEART Models offers seamless integration with major electroanatomic mapping (EAM) systems such as Cartou00ae, Rhythmiau2122, Ensiteu2122, and Afferau2122. Autoplaque is described as a workstation-based post-processing application, with no specific integrations mentioned.
Autoplaque features automated vessel, plaque, and lumen segmentation that is reviewable and editable by the clinician, along with review in Multiplanar Reformatting (MPR) views. inHEART Models offers AI-driven automated segmentation of CT and MR images to create its detailed 3D cardiac models.
AI Tool Finder
AI-powered search. Results may not be comprehensive.